1. Home
  2. OFIX vs PEPG Comparison

OFIX vs PEPG Comparison

Compare OFIX & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

N/A

Current Price

$12.03

Market Cap

500.2M

Sector

Health Care

ML Signal

N/A

Logo PepGen Inc.

PEPG

PepGen Inc.

N/A

Current Price

$6.15

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFIX
PEPG
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
500.2M
440.0M
IPO Year
1998
2022

Fundamental Metrics

Financial Performance
Metric
OFIX
PEPG
Price
$12.03
$6.15
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$17.25
$11.67
AVG Volume (30 Days)
274.2K
618.9K
Earning Date
05-18-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
25.61
EPS
N/A
N/A
Revenue
$822,312,000.00
N/A
Revenue This Year
$6.32
N/A
Revenue Next Year
$6.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$10.25
$0.89
52 Week High
$17.00
$7.80

Technical Indicators

Market Signals
Indicator
OFIX
PEPG
Relative Strength Index (RSI) 29.82 51.50
Support Level $10.55 $4.36
Resistance Level $16.50 $6.81
Average True Range (ATR) 0.58 0.55
MACD -0.08 -0.04
Stochastic Oscillator 6.71 55.11

Price Performance

Historical Comparison
OFIX
PEPG

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: